Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Thymopent aqueous solution preparation and use thereof

A technology of aqueous solution and thymus, which is applied in the application of medicine, pharmaceutical preparations, and the field of aqueous solution preparations of thymopentin, can solve the problems of unable to maintain the stability of the solution, shorten the time of stable storage, and lack of drugs in patients, so as to prevent free calcium The effect of the rapid decrease of the concentration, the reduction of the cost of the drug, and the timely demand for the drug

Active Publication Date: 2013-09-25
JINZHOU AHON PHARM CO LTD
View PDF2 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] From the above patent information, it can be seen that by adding protective agents, antioxidants, pH regulators and other auxiliary materials in combination with the active ingredients of thymopentin, it can stabilize the thymopentin aqueous solution as a whole, especially at low temperatures of 2-10 °C , are easy to store stably, but as the temperature rises, such as at room temperature, the time of stable storage is significantly shortened, and at an environment higher than room temperature, especially higher than 40 ° C, the stability of the solution cannot be basically maintained sex
[0011] During the transportation of medicines in summer, the outdoor temperature is often above 40°C. The use of special transportation vehicles with cooling equipment not only increases the cost, but also has great limitations. Therefore, it is necessary to provide a thymopentin water-soluble preparation with higher stability, especially at a higher temperature of 40°C.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Thymopent aqueous solution preparation and use thereof
  • Thymopent aqueous solution preparation and use thereof
  • Thymopent aqueous solution preparation and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Accurately weigh 0.1g of thymopentin, 0.015g of sodium acetate, 1.485g of glacial acetic acid, 0.5g of calcium sodium edetate, and 0.3g of sodium chloride, dissolve them in water for injection, and finally dissolve them to 1000ml. The ampoules are divided into 1000 sticks. The final specification is 1ml / branch.

Embodiment 2

[0040] Accurately weigh 100g of thymopentin, 9.655g of sodium acetate, 990.345g of glacial acetic acid, 40g of calcium sodium ethylenediaminetetraacetate, and 200g of sodium chloride, dissolve them in water for injection, and finally dissolve them to 1000ml, and divide them into 2ml glass ampoules. Packed into 1000 pieces. The final specification is 1ml / branch.

Embodiment 3

[0042] Accurately weigh 10g of thymopentin, 0.966g of sodium acetate, 99.034g of glacial acetic acid, 10g of calcium sodium edetate, and 20g of sodium chloride, dissolve them in water for injection, and finally dissolve them to 1000ml. Packed into 1000 pieces. The final specification is 1ml / branch.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses a thymopent aqueous solution preparation, wherein thymopent is adopted as an active component raw material, a pharmaceutical adjuvant and water are added, and mixing is performed to prepare the thymopent aqueous solution preparation, wherein the adjuvant comprises an acetic acid-sodium acetate buffer solution adopted as a pH value adjustment agent, calcium sodium ethylene diaminetetracetate adopted as a protection agent, and sodium chloride adopted as an osmotic pressure adjustment agent, the thymopent amount is 0.1-100 mg / ml, the acetic acid-sodium acetate buffer solution amount is 1.5-1500 mg / ml, the calcium sodium ethylene diaminetetracetate amount is 0.1-40 mg / ml, and the sodium chloride amount is 0.3-300 mg / ml. The thymopent aqueous solution preparation has characteristics of stable low temperature long-time storage, stable room temperature storage, and stability under a strong illumination condition, and does not generate significant change after storing for 5 days at a high temperature of 60 DEG C so as to reduce transportation requirements, provide convenience for drug transportation, substantially reduce a drug cost, and timely provide drug requirements for patients.

Description

technical field [0001] The invention relates to a pharmaceutical preparation, in particular to an aqueous solution preparation of thymopentin and its application in the preparation of medicines for treating chronic viral hepatitis, tumors and other immune diseases, and belongs to the field of medicines. Background technique [0002] Thymopentin (TP-5) consists of 5 amino acid residues (Arg-Lys-Asp-Val-Tyr), which is similar to 32-36 of the 49 amino acids of thymopoietin (TP) The bit sequence is the same, and it has been proved that TP-5 is a functionally active fragment of TP, and TP-5 has similar physiological activities of TP. [0003] Pharmacological effects of thymopentin: it is an immunomodulatory drug, one of its functions is to induce T cell differentiation. It selectively induces the conversion of Thy-1- prothymocytes into Thy-1+ T cells. Its T cell differentiation is mediated by increased intracellular cAMP levels. Another basic role of thymopentin is to bind to ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/08A61K38/08A61K47/22A61K47/12A61K47/02A61P1/16A61P31/12A61P35/00A61P37/02
Inventor 张玲李博
Owner JINZHOU AHON PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products